etiocholanolone has been researched along with Cancer of Prostate in 16 studies
Etiocholanolone: The 5-beta-reduced isomer of ANDROSTERONE. Etiocholanolone is a major metabolite of TESTOSTERONE and ANDROSTENEDIONE in many mammalian species including humans. It is excreted in the URINE.
3alpha-hydroxy-5beta-androstan-17-one : An androstanoid that is 5beta-androstane substituted by an alpha-hydroxy group at position 3 and an oxo group at position 17. It is a metabolite of testosterone in mammals.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The survival and progression of prostate cancer are generally dependent on expression of the androgen receptor (AR), as well as the availability of endogenous AR agonists." | 2.48 | The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer. ( Sharifi, N, 2012) |
| "Inanition and obesity have been shown to alter steroid metabolism but it is not known whether nutritional "microdifferences" (i." | 2.35 | Hormone profiles in hormone-dependent cancers. ( Bradlow, HL; Fishman, J; Hellman, L; Zumoff, B, 1975) |
| "Almost all prostate cancers recur during androgen deprivation therapy, and new evidence suggests that androgen receptor activation persists despite castrate levels of circulating androgens." | 1.36 | Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer. ( Lih, FB; Mohler, JL; Titus, MA; Tomer, KB, 2010) |
| "In these prostatic cancer patients, plasma androgen levels decreased, while estrogen levels increased." | 1.26 | Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer. ( Garbaczewski, L; Hill, P; Walker, AR; Wynder, EL, 1982) |
| "In patients with breast and prostate cancer hormone excretion patterns differ in a similar way from patterns in persons without cancer." | 1.24 | HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. ( HOPKINS, CE; MARMORSTON, J; STERN, E; WEINER, JM, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| DE Luca, S | 1 |
| Amante, E | 1 |
| Fiori, C | 1 |
| Alleva, G | 1 |
| Alladio, E | 1 |
| Marini, F | 1 |
| Garrou, D | 1 |
| Manfredi, M | 1 |
| Amparore, D | 1 |
| Checcucci, E | 1 |
| Pruner, S | 1 |
| Salomone, A | 1 |
| Scarpa, RM | 1 |
| Vincenti, M | 1 |
| Porpiglia, F | 1 |
| Alevizopoulos, K | 1 |
| Dimas, K | 1 |
| Papadopoulou, N | 1 |
| Schmidt, EM | 1 |
| Tsapara, A | 1 |
| Alkahtani, S | 1 |
| Honisch, S | 1 |
| Prousis, KC | 1 |
| Alarifi, S | 1 |
| Calogeropoulou, T | 1 |
| Lang, F | 1 |
| Stournaras, C | 1 |
| Lih, FB | 1 |
| Titus, MA | 1 |
| Mohler, JL | 1 |
| Tomer, KB | 1 |
| Sharifi, N | 2 |
| BRADSHAW, LR | 1 |
| BAGNESS, JE | 1 |
| PYRAH, LN | 1 |
| RAPER, FP | 1 |
| STERN, E | 2 |
| HOPKINS, CE | 2 |
| WEINER, JM | 1 |
| MARMORSTON, J | 2 |
| LOMBARDO, LJ | 1 |
| MYERS, SM | 1 |
| GIERSON, H | 1 |
| Hill, P | 1 |
| Wynder, EL | 1 |
| Garbaczewski, L | 1 |
| Walker, AR | 1 |
| Délos, S | 1 |
| Carsol, JL | 1 |
| Ghazarossian, E | 1 |
| Raynaud, JP | 1 |
| Martin, PM | 1 |
| Negri-Cesi, P | 1 |
| Colciago, A | 1 |
| Poletti, A | 1 |
| Motta, M | 1 |
| Zumoff, B | 1 |
| Fishman, J | 1 |
| Bradlow, HL | 1 |
| Hellman, L | 1 |
| Garnham, JR | 1 |
| Bulbrook, RD | 1 |
| Wang, DY | 1 |
| Bird, CE | 1 |
| Clark, AF | 1 |
| Harkness, RA | 1 |
| Bell, ET | 1 |
| Loraine, JA | 1 |
| Ismail, AA | 1 |
| Morse, WI | 1 |
3 reviews available for etiocholanolone and Cancer of Prostate
| Article | Year |
|---|---|
Clinical implications of the 5α-androstanedione pathway for castration-resistant prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; Abiraterone Acetate; Androstadienes; Androstenediol; Antineoplastic | 2011 |
The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer.
Topics: Abiraterone Acetate; Androstadienes; Biosynthetic Pathways; Dihydrotestosterone; Etiocholanolone; Hu | 2012 |
Hormone profiles in hormone-dependent cancers.
Topics: Adrenalectomy; Adult; Age Factors; Androgens; Androsterone; Breast Neoplasms; China; Epidemiologic M | 1975 |
1 trial available for etiocholanolone and Cancer of Prostate
| Article | Year |
|---|---|
The effects of clomiphene on endocrine function in male patients with adrenocortical infufficiency and following castration.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Addison Disease; Adrenal Glands; Adrenal Insufficiency; | 1968 |
12 other studies available for etiocholanolone and Cancer of Prostate
| Article | Year |
|---|---|
Prospective evaluation of urinary steroids and prostate carcinoma-induced deviation: preliminary results.
Topics: Aged; Biomarkers; Dehydroepiandrosterone; Etiocholanolone; Gas Chromatography-Mass Spectrometry; Hum | 2021 |
Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor.
Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Clinical Trials, Phase II as To | 2016 |
Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer.
Topics: Androgens; Atmospheric Pressure; Chromatography, High Pressure Liquid; Dihydrotestosterone; Etiochol | 2010 |
A STUDY OF STEROID EXCRETION IN PATIENTS WITH PROSTATIC CANCER.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androsterone; Biopsy; Cortisone; Dehydroepiandrosterone; D | 1964 |
HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androsterone; Breast Neoplasms; Creatine; Creatinine | 1964 |
URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANEDIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY.
Topics: 17-Ketosteroids; Androsterone; Blood Glucose; Blood Urea Nitrogen; Creatine; Creatinine; Etiocholano | 1965 |
Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer.
Topics: Aged; Androgens; Androsterone; Black People; Dehydroepiandrosterone; Diet; Estriol; Estrogens; Estro | 1982 |
Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenosarcoma; Androstenedione; Azasteroids; Blotting, Northern; Ce | 1995 |
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase | 1999 |
Hormone profiles and discriminant functions in cancer.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Breast Neoplasms; Etiocholanolone; Female; Human | 1970 |
Conjugated and unconjugated dehydroepiandrosterone, aetiocholanolone and androsterone in the peripheral plasma of patients with cancer of the breast, ovary, uterus or prostate.
Topics: Adult; Androsterone; Breast Neoplasms; Dehydroepiandrosterone; Etiocholanolone; Female; Humans; Male | 1969 |
A single method for determination of urine steroids. I. Levels of testosterone, epitestosterone and 17-ketosteroid fractions. II. Specific activities of testosterone, androsterone and etiocholanolone and production rate of testosterone following administr
Topics: 17-Ketosteroids; Adolescent; Adult; Aged; Androsterone; Breast Neoplasms; Carbon Isotopes; Carcinoma | 1970 |